ANGELA STERIOUS: Open Payments
NPI 1952717415 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,526 in 25 payments from 17 companies in 2025. Trend: 2023 $2,005 · 2024 $2,213 · 2025 $2,526
Food & beverage: $2,526
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $380 |
| Lilly USA, LLC | 3 | $253 |
| Otsuka America Pharmaceutical, Inc. | 2 | $220 |
| ABBVIE INC. | 3 | $176 |
| Exact Sciences Corporation | 2 | $143 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Astellas Pharma US Inc | 1 | $140 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Biogen, Inc. | 1 | $120 |
Products named: CAPLYTA, REXULTI, Cologuard Collection Kit, REZDIFFRA, Veozah, VRAYLAR, ZURZUVAE, KISUNLA.
Industry payments across FL — which companies pay providers there.
